Literature DB >> 9425228

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.

N Soufir1, M F Avril, A Chompret, F Demenais, J Bombled, A Spatz, D Stoppa-Lyonnet, J Bénard, B Bressac-de Paillerets.   

Abstract

Germline mutations in the p16 and CDK4 genes have been reported in a subset of melanoma pedigrees, but their prevalence is not well known. We searched for such germline mutations in 48 French melanoma-prone families selected according to two major criteria: families with at least three affected members (n = 20) or families with two affected members, one of them affected before the age of 50 (n = 28), and one additional minor criterion. Sixteen different p16 germline mutations were found in 21 families, while one germline mutation, Arg24His, was detected in the CDK4 gene. The frequency of p16 gene mutation in our sample (44%) is among the highest rates yet reported and the CDK4 mutation is the second mutation detected in this gene worldwide. In summary, our results show frequent involvement of the p16 gene in familial melanoma and confirm the role of the CDK4 gene as a melanoma-predisposing gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9425228     DOI: 10.1093/hmg/7.2.209

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  85 in total

1.  A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.

Authors:  P Ciotti; J P Struewing; M Mantelli; A Chompret; M F Avril; P L Santi; M A Tucker; G Bianchi-Scarrà; B Bressac-de Paillerets; A M Goldstein
Journal:  Am J Hum Genet       Date:  2000-06-22       Impact factor: 11.025

Review 2.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

3.  Expression properties of recombinant pEgr-P16 plasmid in esophageal squamous cell carcinoma induced by ionizing irradiation.

Authors:  Cong-Mei Wu; Tian-Hua Huang; Qing-Dong Xie; De-Sheng Wu; Xiao-Hu Xu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

4.  Localization of a novel melanoma susceptibility locus to 1p22.

Authors:  Elizabeth Gillanders; Suh-Hang Hank Juo; Elizabeth A Holland; MaryPat Jones; Derek Nancarrow; Diana Freas-Lutz; Raman Sood; Naeun Park; Mezbah Faruque; Carol Markey; Richard F Kefford; Jane Palmer; Wilma Bergman; D Timothy Bishop; Margaret A Tucker; Brigitte Bressac-de Paillerets; Johan Hansson; Mitchell Stark; Nelleke Gruis; Julia Newton Bishop; Alisa M Goldstein; Joan E Bailey-Wilson; Graham J Mann; Nicholas Hayward; Jeffrey Trent
Journal:  Am J Hum Genet       Date:  2003-07-03       Impact factor: 11.025

5.  Construction of pETNF-P16 plasmid and its expression properties in EC9706 cell line induced by X-ray irradiation.

Authors:  Cong-Mei Wu; Tian-Hua Huang; Qing-Dong Xie; De-Sheng Wu; Xiao-Hu Xu
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

Review 6.  Hereditary pancreatic cancer.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

7.  High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families.

Authors:  Marko Hocevar; Magdalena Avbelj; Barbara Perić; Janez Zgajnar; Nikola Besić; Tadej Battelino
Journal:  Croat Med J       Date:  2006-12       Impact factor: 1.351

8.  Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.

Authors:  Ichiro Okamoto; Christine Pirker; Martin Bilban; Walter Berger; Doris Losert; Christine Marosi; Oskar A Haas; Klaus Wolff; Hubert Pehamberger
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

9.  Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.

Authors:  Marcelo L Rodriguez-Puebla; Paula L Miliani de Marval; Margaret LaCava; David S Moons; Hiroaki Kiyokawa; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

10.  Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3.

Authors:  Juliette Delaunay; Ludovic Martin; Brigitte Bressac-de Paillerets; Gerard Duru; Olivier Ingster; Luc Thomas
Journal:  JAMA Dermatol       Date:  2017-11-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.